OBE022, an Oral and Selective Prostaglandin F2{alpha} Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor [Drug Discovery and Translational Medicine]

Pohl, O., Chollet, A., Kim, S. H., Riaposova, L., Spezia, F., Gervais, F., Guillaume, P., Lluel, P., Meen, M., Lemaux, F., Terzidou, V., Bennett, P. R., Gotteland, J.-P.
The American Society for Pharmacology and Experimental Therapeutics
Published 2018